Skip to main content
Clinical Trials/NCT01696903
NCT01696903CompletedNot Applicable

Clinical Randomized Trial Investigating a Novel Pancreaticojejunostomy Technique for Pancreaticoduodenectomy in Patients With a High Risk for Postoperative Pancreatic Fistula

Karolinska Institutet2 sites in 1 country123 target enrollmentStarted: September 1, 2011Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
123
Locations
2
Primary Endpoint
Clinically Relevant Postoperative Pancreatic Fistula

Study Overview

Brief Summary

Pancreaticoduodenectomy is a surgical procedure for removing cancer in the pancreas, the bile system or the duodenum that is associated with a high rate of complications. The study wants to investigate whether a new technique to reconstruct the joint between the pancreatic gland and the short bowel can reduce the rate of severe complications after this complex surgical procedure.

Detailed Description

Pancreaticoduodenectomy is a complex surgical procedure for radically resecting tumors in the pancreatic head, distal bile duct or duodenum. Postoperative pancreatic fistula is the main contributor of severe postoperative morbidity after pancreaticoduodenectomy. Characteristics of the pancreatic gland like soft pancreatic consistency and small pancreatic main duct predispose for the postoperative fistula development. In high risk patients, the risk of suffering from associated postoperative morbidity is 50 percent which is considered unacceptable high. The aim of the current trial is to investigate whether a new anastomosing technique for the pancreaticojejunostomy can reduce the incidence of associated postoperative morbidity in patients undergoing pancreaticoduodenectomy.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients scheduled for elective pancreaticoduodenectomy
  • •Pancreatic gland with high risk criteria for associated postoperative morbidity

Exclusion Criteria

  • •Patients do not accept participation
  • •Pancreatic gland with intermediate or low risk criteria for associated postoperative morbidity

Arms & Interventions

Conventional anastomosis

No Intervention

Conventional anastomosis: The pancreaticojejunostomy is carried out in a traditional way according to "Cattell's duct-to-mucosa technique".

Novel anastomosis

Active Comparator

Novel anastomosis: This the active comparator to the conventional anastomosis. A new pancreaticojejunostomy technique is used for the reconstruction. The pancreas is intubated into the jejunum.

Intervention: Pancreaticojejunostomy technique (Procedure)

Outcomes

Primary Outcomes

Clinically Relevant Postoperative Pancreatic Fistula

Time Frame: participants will be followed for the duration of hospital stay, an expected average of 2 weeks

Postoperative pancreatic fistula as defined by the International Study Group of Pancreatic Fistula

Secondary Outcomes

  • Associated postoperative morbidity(participants will be followed for the duration of hospital stay, an expected average of 2 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Christoph Ansorge

Christoph Ansorge, MD, PhD

Karolinska Institutet

Study Sites (2)

Loading locations...

Similar Trials

Evaluation of a Novel... | Clinical Trial